Humana Q2 Earnings: Analysts Expect 9.2% EPS Decline and 8.2% Revenue Growth
PorAinvest
martes, 29 de julio de 2025, 1:16 am ET1 min de lectura
CNC--
Key Metrics:
- Revenues-Premiums: Analysts predict this metric to reach $30.23 billion, a 7.4% YoY increase.
- Revenues-Services: This is estimated to reach $1.31 billion, a 19% YoY increase.
- Revenues-Investment Income (Loss): Expected to be $270.96 million, down 9.1% YoY.
- Revenue-Insurance: Predicted to be $30.71 billion.
- Medical Membership-Medicare Stand-Alone PDP: Expected to reach 2.45 million.
The consensus estimate for full-year 2025 revenues is $126.1 billion, a 7.6% YoY increase, with current year EPS pegged at $16.37, implying a 1% YoY gain [2]. Humana has beaten earnings estimates in the past four quarters, with an average surprise of 14.3% [3].
Peer Performance:
- Centene Corporation (CNC) reported a loss of 16 cents per share, missing the Zacks Consensus Estimate.
- Molina Healthcare (MOH) reported adjusted EPS of $5.48, missing the estimate by 1.1%.
- Elevance Health (ELV) reported adjusted EPS of $8.84, missing the estimate by 3.5%.
Humana's earnings are expected to be driven by premium growth and service revenues, while investment income and operating costs are anticipated to have a negative impact. The company's Zacks Rank is #3, and it has an Earnings ESP of +10.51%, increasing the odds of an earnings beat [1].
References:
[1] https://finance.yahoo.com/news/humana-beat-q2-earnings-estimates-152600292.html
[2] https://www.tradingview.com/news/zacks:71aefa8d1094b:0-can-humana-beat-q2-earnings-estimates-on-insurance-unit-strength/
[3] https://www.nasdaq.com/articles/curious-about-humana-hum-q2-performance-explore-wall-street-estimates-key-metrics
ELV--
HUM--
MOH--
Humana (HUM) Q2 earnings expected to decline 9.2% YoY to $6.32/share, with revenues forecast to increase 8.2% YoY to $31.78 billion. Analysts predict specific metrics such as 'Revenues-Premiums' to reach $30.23 billion, a 7.4% YoY change, and 'Medical Membership-Medicare stand-alone PDP' to reach 2.45 million.
Humana Inc. (HUM) is set to report its second-quarter 2025 earnings on July 30, with analysts predicting a 9.2% year-over-year (YoY) decline in earnings per share (EPS) to $6.32. Revenue is forecast to increase by 8.2% YoY to $31.78 billion [1].Key Metrics:
- Revenues-Premiums: Analysts predict this metric to reach $30.23 billion, a 7.4% YoY increase.
- Revenues-Services: This is estimated to reach $1.31 billion, a 19% YoY increase.
- Revenues-Investment Income (Loss): Expected to be $270.96 million, down 9.1% YoY.
- Revenue-Insurance: Predicted to be $30.71 billion.
- Medical Membership-Medicare Stand-Alone PDP: Expected to reach 2.45 million.
The consensus estimate for full-year 2025 revenues is $126.1 billion, a 7.6% YoY increase, with current year EPS pegged at $16.37, implying a 1% YoY gain [2]. Humana has beaten earnings estimates in the past four quarters, with an average surprise of 14.3% [3].
Peer Performance:
- Centene Corporation (CNC) reported a loss of 16 cents per share, missing the Zacks Consensus Estimate.
- Molina Healthcare (MOH) reported adjusted EPS of $5.48, missing the estimate by 1.1%.
- Elevance Health (ELV) reported adjusted EPS of $8.84, missing the estimate by 3.5%.
Humana's earnings are expected to be driven by premium growth and service revenues, while investment income and operating costs are anticipated to have a negative impact. The company's Zacks Rank is #3, and it has an Earnings ESP of +10.51%, increasing the odds of an earnings beat [1].
References:
[1] https://finance.yahoo.com/news/humana-beat-q2-earnings-estimates-152600292.html
[2] https://www.tradingview.com/news/zacks:71aefa8d1094b:0-can-humana-beat-q2-earnings-estimates-on-insurance-unit-strength/
[3] https://www.nasdaq.com/articles/curious-about-humana-hum-q2-performance-explore-wall-street-estimates-key-metrics

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios